Working… Menu

Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting (DHA-WIN)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03831178
Recruitment Status : Recruiting
First Posted : February 5, 2019
Last Update Posted : October 2, 2019
Canadian Institutes of Health Research (CIHR)
University of Alberta
Information provided by (Responsible Party):
AHS Cancer Control Alberta